Recent MRNA Stock Price | MRNA Stock Predictions | |
$42.39 | +77.26% |
$75.14 |
Recent MRNA Analyst Ratings Breakdown, Making MRNA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 16 | 16 | 16 | 15 |
Sell ratings: | 1 | 1 | 0 | 0 |
Strong sell ratings: | 3 | 3 | 3 | 2 |
Average rating: | 2.88 | 2.88 | 2.76 | 2.65 |
For the MRNA stock predictions from the analysts covering Moderna Inc, we have collected all of the individual MRNA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 22 different analysts covering MRNA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MRNA stock predictions may vary widely, another useful metric to consider is the median MRNA stock prediction, which represents the price at which half of the analysts
made MRNA stock predictions that were higher and half made MRNA stock predictions that were lower. This makes for a different take on the MRNA stock predictions out there, as compared to average or mean.
And that median across all the individual MRNA stock predictions was: $59.0 as of 2025-01-24.
The very highest of the MRNA stock predictions for one year price target was $212.0, while the very lowest of the MRNA stock predictions in the analyst group was
$27.0 (with a standard deviation of $50.1). Get the latest Zacks research report on MRNA — FREE
Find out: MRNA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
STAA Stock Predictions
GFL Stock Predictions
NSA Stock Predictions
TRI Stock Predictions
DRI Stock Predictions
MA Stock Predictions
HIBB Stock Predictions
UPWK Stock Predictions
DHT Stock Predictions
|
|
Hold (2.12 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |